register

News & Trends - Biotechnology

Parliament House hosts biotech policy forum

Health Industry Hub | November 17, 2023 |

Biotech News: Canberra’s Parliament House hosted biotech leaders for strategic discussions and insightful presentations. The AusBiotech annual Policy Forum marked a significant collaboration between industry and government officials, underscoring the vital intersection of capital, policy and innovation shaping the evolving biotechnology landscape.

The 2023 CEO delegation, comprising Amplia Therapeutics, BioDiem, CSL, Esfam Biotech, Microbio, SpeeDx, Relix Pharmaceuticals, UniQuest, Vaxxas, and others, focussed on pivotal discussions revolving around the vitality of financial capital, deemed the ‘lifeblood’ nurturing the growth of the biotech sector. These discussions delved into capital attraction initiatives and opportunities outlined in the Biotechnology Blueprint.

In attendance were The Hon Ed Husic (MP), Minister for Industry and Science, along with notable representatives from the Department of Health and Aged Care, the Department of Industry, Science and Resources, and Treasury.

The AusBiotech CEO Policy Forum served as a pivotal platform for biotech leaders to gain insights into the government’s objectives. Simultaneously, it provided a unique opportunity for government officials to delve deeper into the impact of life sciences on the nation’s economy.

Central to the discussions were key policy areas that underpin the biotech sector’s progress, including the implications of quantum advancements on biotech, policy mechanisms to allure greater private investments, and the scope of government funding within the industry. A CEO workshop further fostered discussions on proactive policy initiatives aimed at supporting industry-driven medical research, effectively charting the trajectory for AusBiotech’s future policy endeavours and advocacy work.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.